AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.450
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
3.304
-0.146 (-4.23%)
Pre-market: Jan 2, 2026, 8:00 AM EST
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $105.87 million as of January 2, 2026. Its market cap has decreased by -66.93% in one year.
Market Cap
105.87M
Enterprise Value
127.33M
1-Year Change
-66.93%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since October 2, 2019, AVITA Medical's market cap has decreased from $666.70M to $105.87M, a decrease of -84.12%. That is a compound annual growth rate of -25.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 105.20M | -68.65% |
| Dec 31, 2024 | 335.60M | -4.28% |
| Dec 29, 2023 | 350.60M | 112.23% |
| Dec 30, 2022 | 165.20M | -44.68% |
| Dec 31, 2021 | 298.60M | -25.68% |
| Dec 31, 2020 | 401.80M | -52.81% |
| Dec 31, 2019 | 851.40M | 27.70% |
| Oct 2, 2019 | 666.70M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |